The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain

Valeria Tronci, David J. K. Balfour

    Research output: Contribution to journalArticle

    15 Citations (Scopus)

    Abstract

    Previous studies have shown that the prior administration of metabotropic glutamate receptor 5 (MGluR5) receptor antagonists inhibit responding for nicotine in an intravenous self-administration experiment. However, recent studies in this laboratory have shown that an mGluR5 receptor antagonist, MPEP (2-methyl-6-(phenylethynyl)-pyridine), also attenuates contextually-conditioned responding evoked by cues associated with the delivery or availability of nicotine. Thus, the results to date do not provide unequivocal evidence that the effects of mGluR5 receptor antagonists on responding for nicotine reflect a direct functional interaction between the antagonists and nicotine per se. This study employed in vivo microdialysis to test the hypothesis that the prior administration of the mGluR5 receptor antagonist, MPEP, inhibits a neural response to nicotine, increased dopamine (DA) overflow in the nucleus accumbens, implicated in directly in nicotine reinforcement. The results confirmed that prior administration of MPEP (2.5 mg/kg and 5 mg/kg IP) dose-dependently reduced responding for nicotine in a self-administration experiment. The higher dose caused complete inhibition of responding in a majority of the animals tested. MPEP injections, over the same dose range, also inhibited the effects of nicotine on DA overflow in the shell and core subdivisions of the rat nucleus accumbens. It is concluded that the data support the hypothesis that, in addition to their putative role in contextually-conditioned responding for nicotine, mGluR5 receptors are also implicated the primary reinforcing properties of the drug which depend upon increased DA overflow in the nucleus accumbens. (C) 2010 Elsevier B.V. All rights reserved.

    Original languageEnglish
    Pages (from-to)354-357
    Number of pages4
    JournalBehavioural Brain Research
    Volume219
    Issue number2
    DOIs
    Publication statusPublished - 1 Jun 2011

    Keywords

    • Nicotine reinforcement
    • dopamine
    • 6-methyl-2-(phenylethynyl)-pyridine (MPEP)
    • Nucleus accumbens
    • NUCLEUS-ACCUMBENS CORE
    • COCAINE-SEEKING BEHAVIOR
    • DECREASED NICOTINE
    • SHELL
    • ADDICTION
    • RESPONSES
    • SYSTEM

    Cite this

    @article{bddd03a885634d199a2fc9a1464efa9b,
    title = "The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain",
    abstract = "Previous studies have shown that the prior administration of metabotropic glutamate receptor 5 (MGluR5) receptor antagonists inhibit responding for nicotine in an intravenous self-administration experiment. However, recent studies in this laboratory have shown that an mGluR5 receptor antagonist, MPEP (2-methyl-6-(phenylethynyl)-pyridine), also attenuates contextually-conditioned responding evoked by cues associated with the delivery or availability of nicotine. Thus, the results to date do not provide unequivocal evidence that the effects of mGluR5 receptor antagonists on responding for nicotine reflect a direct functional interaction between the antagonists and nicotine per se. This study employed in vivo microdialysis to test the hypothesis that the prior administration of the mGluR5 receptor antagonist, MPEP, inhibits a neural response to nicotine, increased dopamine (DA) overflow in the nucleus accumbens, implicated in directly in nicotine reinforcement. The results confirmed that prior administration of MPEP (2.5 mg/kg and 5 mg/kg IP) dose-dependently reduced responding for nicotine in a self-administration experiment. The higher dose caused complete inhibition of responding in a majority of the animals tested. MPEP injections, over the same dose range, also inhibited the effects of nicotine on DA overflow in the shell and core subdivisions of the rat nucleus accumbens. It is concluded that the data support the hypothesis that, in addition to their putative role in contextually-conditioned responding for nicotine, mGluR5 receptors are also implicated the primary reinforcing properties of the drug which depend upon increased DA overflow in the nucleus accumbens. (C) 2010 Elsevier B.V. All rights reserved.",
    keywords = "Nicotine reinforcement, dopamine, 6-methyl-2-(phenylethynyl)-pyridine (MPEP), Nucleus accumbens, NUCLEUS-ACCUMBENS CORE, COCAINE-SEEKING BEHAVIOR, DECREASED NICOTINE, SHELL, ADDICTION, RESPONSES, SYSTEM",
    author = "Valeria Tronci and Balfour, {David J. K.}",
    year = "2011",
    month = "6",
    day = "1",
    doi = "10.1016/j.bbr.2010.12.024",
    language = "English",
    volume = "219",
    pages = "354--357",
    journal = "Behavioural Brain Research",
    issn = "0166-4328",
    publisher = "Elsevier",
    number = "2",

    }

    The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain. / Tronci, Valeria; Balfour, David J. K.

    In: Behavioural Brain Research, Vol. 219, No. 2, 01.06.2011, p. 354-357.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain

    AU - Tronci, Valeria

    AU - Balfour, David J. K.

    PY - 2011/6/1

    Y1 - 2011/6/1

    N2 - Previous studies have shown that the prior administration of metabotropic glutamate receptor 5 (MGluR5) receptor antagonists inhibit responding for nicotine in an intravenous self-administration experiment. However, recent studies in this laboratory have shown that an mGluR5 receptor antagonist, MPEP (2-methyl-6-(phenylethynyl)-pyridine), also attenuates contextually-conditioned responding evoked by cues associated with the delivery or availability of nicotine. Thus, the results to date do not provide unequivocal evidence that the effects of mGluR5 receptor antagonists on responding for nicotine reflect a direct functional interaction between the antagonists and nicotine per se. This study employed in vivo microdialysis to test the hypothesis that the prior administration of the mGluR5 receptor antagonist, MPEP, inhibits a neural response to nicotine, increased dopamine (DA) overflow in the nucleus accumbens, implicated in directly in nicotine reinforcement. The results confirmed that prior administration of MPEP (2.5 mg/kg and 5 mg/kg IP) dose-dependently reduced responding for nicotine in a self-administration experiment. The higher dose caused complete inhibition of responding in a majority of the animals tested. MPEP injections, over the same dose range, also inhibited the effects of nicotine on DA overflow in the shell and core subdivisions of the rat nucleus accumbens. It is concluded that the data support the hypothesis that, in addition to their putative role in contextually-conditioned responding for nicotine, mGluR5 receptors are also implicated the primary reinforcing properties of the drug which depend upon increased DA overflow in the nucleus accumbens. (C) 2010 Elsevier B.V. All rights reserved.

    AB - Previous studies have shown that the prior administration of metabotropic glutamate receptor 5 (MGluR5) receptor antagonists inhibit responding for nicotine in an intravenous self-administration experiment. However, recent studies in this laboratory have shown that an mGluR5 receptor antagonist, MPEP (2-methyl-6-(phenylethynyl)-pyridine), also attenuates contextually-conditioned responding evoked by cues associated with the delivery or availability of nicotine. Thus, the results to date do not provide unequivocal evidence that the effects of mGluR5 receptor antagonists on responding for nicotine reflect a direct functional interaction between the antagonists and nicotine per se. This study employed in vivo microdialysis to test the hypothesis that the prior administration of the mGluR5 receptor antagonist, MPEP, inhibits a neural response to nicotine, increased dopamine (DA) overflow in the nucleus accumbens, implicated in directly in nicotine reinforcement. The results confirmed that prior administration of MPEP (2.5 mg/kg and 5 mg/kg IP) dose-dependently reduced responding for nicotine in a self-administration experiment. The higher dose caused complete inhibition of responding in a majority of the animals tested. MPEP injections, over the same dose range, also inhibited the effects of nicotine on DA overflow in the shell and core subdivisions of the rat nucleus accumbens. It is concluded that the data support the hypothesis that, in addition to their putative role in contextually-conditioned responding for nicotine, mGluR5 receptors are also implicated the primary reinforcing properties of the drug which depend upon increased DA overflow in the nucleus accumbens. (C) 2010 Elsevier B.V. All rights reserved.

    KW - Nicotine reinforcement

    KW - dopamine

    KW - 6-methyl-2-(phenylethynyl)-pyridine (MPEP)

    KW - Nucleus accumbens

    KW - NUCLEUS-ACCUMBENS CORE

    KW - COCAINE-SEEKING BEHAVIOR

    KW - DECREASED NICOTINE

    KW - SHELL

    KW - ADDICTION

    KW - RESPONSES

    KW - SYSTEM

    U2 - 10.1016/j.bbr.2010.12.024

    DO - 10.1016/j.bbr.2010.12.024

    M3 - Article

    VL - 219

    SP - 354

    EP - 357

    JO - Behavioural Brain Research

    JF - Behavioural Brain Research

    SN - 0166-4328

    IS - 2

    ER -